Switch to:
Also traded in: Germany, UK, USA

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.06
SNN's Cash-to-Debt is ranked lower than
94% of the 269 Companies
in the Global Medical Devices industry.

( Industry Median: 1.84 vs. SNN: 0.06 )
Ranked among companies with meaningful Cash-to-Debt only.
SNN' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.06  Med: 0.17 Max: 2.58
Current: 0.06
0.06
2.58
Equity-to-Asset 0.54
SNN's Equity-to-Asset is ranked lower than
61% of the 254 Companies
in the Global Medical Devices industry.

( Industry Median: 0.62 vs. SNN: 0.54 )
Ranked among companies with meaningful Equity-to-Asset only.
SNN' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.34  Med: 0.54 Max: 0.7
Current: 0.54
0.34
0.7
Interest Coverage 15.51
SNN's Interest Coverage is ranked lower than
68% of the 228 Companies
in the Global Medical Devices industry.

( Industry Median: 83.04 vs. SNN: 15.51 )
Ranked among companies with meaningful Interest Coverage only.
SNN' s Interest Coverage Range Over the Past 10 Years
Min: 8.87  Med: 16.93 Max: 94
Current: 15.51
8.87
94
Piotroski F-Score: 7
Altman Z-Score: 4.53
Beneish M-Score: -2.26
WACC vs ROIC
6.22%
11.26%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 17.27
SNN's Operating Margin % is ranked higher than
86% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. SNN: 17.27 )
Ranked among companies with meaningful Operating Margin % only.
SNN' s Operating Margin % Range Over the Past 10 Years
Min: 13.55  Med: 17.89 Max: 23.22
Current: 17.27
13.55
23.22
Net Margin % 17.21
SNN's Net Margin % is ranked higher than
89% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: 2.51 vs. SNN: 17.21 )
Ranked among companies with meaningful Net Margin % only.
SNN' s Net Margin % Range Over the Past 10 Years
Min: 8.85  Med: 12.65 Max: 17.43
Current: 17.21
8.85
17.43
ROE % 21.10
SNN's ROE % is ranked higher than
90% of the 249 Companies
in the Global Medical Devices industry.

( Industry Median: 3.48 vs. SNN: 21.10 )
Ranked among companies with meaningful ROE % only.
SNN' s ROE % Range Over the Past 10 Years
Min: 10.47  Med: 19.69 Max: 25.27
Current: 21.1
10.47
25.27
ROA % 11.37
SNN's ROA % is ranked higher than
88% of the 270 Companies
in the Global Medical Devices industry.

( Industry Median: 0.81 vs. SNN: 11.37 )
Ranked among companies with meaningful ROA % only.
SNN' s ROA % Range Over the Past 10 Years
Min: 5.79  Med: 9.82 Max: 13.65
Current: 11.37
5.79
13.65
ROC (Joel Greenblatt) % 56.50
SNN's ROC (Joel Greenblatt) % is ranked higher than
88% of the 267 Companies
in the Global Medical Devices industry.

( Industry Median: 7.00 vs. SNN: 56.50 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
SNN' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 30.86  Med: 43.35 Max: 58.51
Current: 56.5
30.86
58.51
3-Year Revenue Growth Rate 12.60
SNN's 3-Year Revenue Growth Rate is ranked higher than
76% of the 228 Companies
in the Global Medical Devices industry.

( Industry Median: 4.60 vs. SNN: 12.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
SNN' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -17.8  Med: 9.6 Max: 37.9
Current: 12.6
-17.8
37.9
3-Year EBITDA Growth Rate 21.50
SNN's 3-Year EBITDA Growth Rate is ranked higher than
77% of the 198 Companies
in the Global Medical Devices industry.

( Industry Median: 4.50 vs. SNN: 21.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
SNN' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -14.6  Med: 11.8 Max: 41.9
Current: 21.5
-14.6
41.9
3-Year EPS without NRI Growth Rate 23.40
SNN's 3-Year EPS without NRI Growth Rate is ranked higher than
77% of the 194 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. SNN: 23.40 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
SNN' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -15  Med: 15.8 Max: 44.2
Current: 23.4
-15
44.2
GuruFocus has detected 5 Warning Signs with Smith & Nephew PLC $SNN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» SNN's 10-Y Financials

Financials (Next Earnings Date: 2017-07-27)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

SNN Guru Trades in Q1 2016

Jim Simons 1,111,500 sh (+267.68%)
Ken Fisher 2,417,325 sh (+9.52%)
Steven Cohen Sold Out
Mario Gabelli 6,675 sh (-1.48%)
» More
Q2 2016

SNN Guru Trades in Q2 2016

Ken Fisher 2,420,956 sh (+0.15%)
Mario Gabelli Sold Out
Jim Simons 850,300 sh (-23.50%)
» More
Q3 2016

SNN Guru Trades in Q3 2016

Ken Fisher 2,479,137 sh (+2.40%)
Jim Simons 764,900 sh (-10.04%)
» More
Q4 2016

SNN Guru Trades in Q4 2016

Steven Cohen 236,800 sh (New)
Ken Fisher 2,404,292 sh (-3.02%)
Jim Simons 701,250 sh (-8.32%)
» More
» Details

Insider Trades

Latest Guru Trades with SNN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339113 
Compare:NYSE:TFX, OTCPK:SONVY, NAS:ALGN, NYSE:EW, NYSE:VAR, OTCPK:CNVVY, OTCPK:CHEOY, OTCPK:WILYY, NYSE:STJ, NAS:ABMD, NYSE:ZBH, NAS:MASI, NAS:NUVA, OTCPK:FSPKF, OTCPK:EKTAF, NAS:IART, OTCPK:GGNDF, NAS:WMGI, NYSE:NVRO, NYSE:GMED » details
Traded in other countries:NPWA.Germany, SN..UK, SNNUF.USA,
Smith & Nephew PLC develops, manufactures, markets and sells medical devices in the sectors of Advanced Surgical Devices and Advanced Wound Management.

Smith & Nephew PLC was incorporated on February 17, 1937. The Company develops, manufactures, markets and sells medical devices. The Company is organized into business segments namely Advanced Surgical Devices and Advanced Wound Management. The Advanced Surgical Devices offers Orthopaedic Reconstruction which includes Hip Implants, Knee Implants and ancillary products, Trauma & Extremities consisting of internal and external devices used in the stabilisation of severe fractures and deformity correction procedures, Sports Medicine Joint Repair, offers surgeons a various instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, Arthroscopy Enabling Technologies offers healthcare providers various technologies such as fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources and monitors to assist with visualisation inside the joints, radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissue. Trauma & Extremities consists of internal and external devices used in the stabilisation of severe fractures and deformity correction procedures. Other Surgical businesses include gynaecological instrumentation as well as various products and technologies to assist in surgical treatment of the ear, nose and throat. Knee Implants, offers products for specialised knee replacement procedures and Hip Implants, offers specialist products for reconstruction of the hip joint. The Advanced Wound Management segment offers Advanced Wound Care, which includes products for the treatment of acute and chronic wounds, including leg, diabetic and pressure ulcers, burns and post-operative wounds, Advanced Wound Devices, consists of traditional and single-use Negative Pressure Wound Therapy and hydrosurgery systems, Advanced Wound Bioactives includes biologics and other bioactive technologies that provide approaches to debridement and dermal repair/regeneration.

Ratios

vs
industry
vs
history
PE Ratio 17.53
SNN's PE Ratio is ranked higher than
75% of the 157 Companies
in the Global Medical Devices industry.

( Industry Median: 27.24 vs. SNN: 17.53 )
Ranked among companies with meaningful PE Ratio only.
SNN' s PE Ratio Range Over the Past 10 Years
Min: 12  Med: 17.42 Max: 43.01
Current: 17.53
12
43.01
Forward PE Ratio 16.78
SNN's Forward PE Ratio is ranked higher than
84% of the 55 Companies
in the Global Medical Devices industry.

( Industry Median: 24.10 vs. SNN: 16.78 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 17.53
SNN's PE Ratio without NRI is ranked higher than
76% of the 157 Companies
in the Global Medical Devices industry.

( Industry Median: 28.18 vs. SNN: 17.53 )
Ranked among companies with meaningful PE Ratio without NRI only.
SNN' s PE Ratio without NRI Range Over the Past 10 Years
Min: 12.38  Med: 20.56 Max: 43.01
Current: 17.53
12.38
43.01
Price-to-Owner-Earnings 15.44
SNN's Price-to-Owner-Earnings is ranked higher than
80% of the 110 Companies
in the Global Medical Devices industry.

( Industry Median: 32.45 vs. SNN: 15.44 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
SNN' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 11.57  Med: 16.23 Max: 47.82
Current: 15.44
11.57
47.82
PB Ratio 3.36
SNN's PB Ratio is ranked lower than
54% of the 250 Companies
in the Global Medical Devices industry.

( Industry Median: 3.09 vs. SNN: 3.36 )
Ranked among companies with meaningful PB Ratio only.
SNN' s PB Ratio Range Over the Past 10 Years
Min: 2.63  Med: 3.89 Max: 7.01
Current: 3.36
2.63
7.01
PS Ratio 2.85
SNN's PS Ratio is ranked higher than
54% of the 252 Companies
in the Global Medical Devices industry.

( Industry Median: 3.24 vs. SNN: 2.85 )
Ranked among companies with meaningful PS Ratio only.
SNN' s PS Ratio Range Over the Past 10 Years
Min: 1.44  Med: 2.83 Max: 4.33
Current: 2.85
1.44
4.33
Price-to-Free-Cash-Flow 29.11
SNN's Price-to-Free-Cash-Flow is ranked higher than
50% of the 102 Companies
in the Global Medical Devices industry.

( Industry Median: 29.41 vs. SNN: 29.11 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
SNN' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 14.01  Med: 24.01 Max: 85.26
Current: 29.11
14.01
85.26
Price-to-Operating-Cash-Flow 15.64
SNN's Price-to-Operating-Cash-Flow is ranked higher than
65% of the 129 Companies
in the Global Medical Devices industry.

( Industry Median: 20.17 vs. SNN: 15.64 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
SNN' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.87  Med: 14.48 Max: 32.24
Current: 15.64
8.87
32.24
EV-to-EBIT 13.66
SNN's EV-to-EBIT is ranked higher than
72% of the 137 Companies
in the Global Medical Devices industry.

( Industry Median: 21.56 vs. SNN: 13.66 )
Ranked among companies with meaningful EV-to-EBIT only.
SNN' s EV-to-EBIT Range Over the Past 10 Years
Min: 8.8  Med: 14.9 Max: 30.7
Current: 13.66
8.8
30.7
EV-to-EBITDA 9.56
SNN's EV-to-EBITDA is ranked higher than
75% of the 142 Companies
in the Global Medical Devices industry.

( Industry Median: 16.07 vs. SNN: 9.56 )
Ranked among companies with meaningful EV-to-EBITDA only.
SNN' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.8  Med: 10.5 Max: 19
Current: 9.56
6.8
19
PEG Ratio 2.51
SNN's PEG Ratio is ranked lower than
53% of the 78 Companies
in the Global Medical Devices industry.

( Industry Median: 2.42 vs. SNN: 2.51 )
Ranked among companies with meaningful PEG Ratio only.
SNN' s PEG Ratio Range Over the Past 10 Years
Min: 0.42  Med: 0.96 Max: 13.95
Current: 2.51
0.42
13.95
Shiller PE Ratio 29.05
SNN's Shiller PE Ratio is ranked higher than
76% of the 50 Companies
in the Global Medical Devices industry.

( Industry Median: 49.99 vs. SNN: 29.05 )
Ranked among companies with meaningful Shiller PE Ratio only.
SNN' s Shiller PE Ratio Range Over the Past 10 Years
Min: 21.48  Med: 29.38 Max: 36.81
Current: 29.05
21.48
36.81
Current Ratio 1.88
SNN's Current Ratio is ranked lower than
61% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 2.24 vs. SNN: 1.88 )
Ranked among companies with meaningful Current Ratio only.
SNN' s Current Ratio Range Over the Past 10 Years
Min: 0.84  Med: 1.84 Max: 2.42
Current: 1.88
0.84
2.42
Quick Ratio 0.95
SNN's Quick Ratio is ranked lower than
78% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 1.64 vs. SNN: 0.95 )
Ranked among companies with meaningful Quick Ratio only.
SNN' s Quick Ratio Range Over the Past 10 Years
Min: 0.47  Med: 0.95 Max: 1.35
Current: 0.95
0.47
1.35
Days Inventory 345.38
SNN's Days Inventory is ranked lower than
89% of the 246 Companies
in the Global Medical Devices industry.

( Industry Median: 125.61 vs. SNN: 345.38 )
Ranked among companies with meaningful Days Inventory only.
SNN' s Days Inventory Range Over the Past 10 Years
Min: 253.48  Med: 320.35 Max: 374.7
Current: 345.38
253.48
374.7
Days Sales Outstanding 98.59
SNN's Days Sales Outstanding is ranked lower than
75% of the 231 Companies
in the Global Medical Devices industry.

( Industry Median: 66.89 vs. SNN: 98.59 )
Ranked among companies with meaningful Days Sales Outstanding only.
SNN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 73.96  Med: 85.38 Max: 98.59
Current: 98.59
73.96
98.59

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 2.06
SNN's Dividend Yield % is ranked higher than
67% of the 189 Companies
in the Global Medical Devices industry.

( Industry Median: 1.74 vs. SNN: 2.06 )
Ranked among companies with meaningful Dividend Yield % only.
SNN' s Dividend Yield % Range Over the Past 10 Years
Min: 0.83  Med: 1.58 Max: 2.3
Current: 2.06
0.83
2.3
Dividend Payout Ratio 0.78
SNN's Dividend Payout Ratio is ranked lower than
80% of the 115 Companies
in the Global Medical Devices industry.

( Industry Median: 0.42 vs. SNN: 0.78 )
Ranked among companies with meaningful Dividend Payout Ratio only.
SNN' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.22  Med: 0.31 Max: 0.78
Current: 0.78
0.22
0.78
3-Year Dividend Growth Rate 16.30
SNN's 3-Year Dividend Growth Rate is ranked higher than
68% of the 78 Companies
in the Global Medical Devices industry.

( Industry Median: 8.40 vs. SNN: 16.30 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
SNN' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -54  Med: 12.65 Max: 19.6
Current: 16.3
-54
19.6
Forward Dividend Yield % 1.60
SNN's Forward Dividend Yield % is ranked higher than
76% of the 181 Companies
in the Global Medical Devices industry.

( Industry Median: 1.81 vs. SNN: 1.60 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 4.31
SNN's 5-Year Yield-on-Cost % is ranked higher than
86% of the 225 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. SNN: 4.31 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
SNN' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.74  Med: 3.3 Max: 4.81
Current: 4.31
1.74
4.81

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 37.51
SNN's Price-to-Tangible-Book is ranked lower than
94% of the 217 Companies
in the Global Medical Devices industry.

( Industry Median: 4.05 vs. SNN: 37.51 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
SNN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.86  Med: 17.51 Max: 66.37
Current: 37.51
4.86
66.37
Price-to-Intrinsic-Value-Projected-FCF 1.66
SNN's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
66% of the 126 Companies
in the Global Medical Devices industry.

( Industry Median: 2.19 vs. SNN: 1.66 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
SNN' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.09  Med: 2.02 Max: 5.92
Current: 1.66
1.09
5.92
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.28
SNN's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
82% of the 22 Companies
in the Global Medical Devices industry.

( Industry Median: 2.39 vs. SNN: 1.28 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.01
SNN's Price-to-Median-PS-Value is ranked higher than
54% of the 211 Companies
in the Global Medical Devices industry.

( Industry Median: 1.06 vs. SNN: 1.01 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
SNN' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.54  Med: 1.22 Max: 2.73
Current: 1.01
0.54
2.73
Price-to-Peter-Lynch-Fair-Value 2.48
SNN's Price-to-Peter-Lynch-Fair-Value is ranked lower than
67% of the 57 Companies
in the Global Medical Devices industry.

( Industry Median: 1.62 vs. SNN: 2.48 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
SNN' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.62  Med: 1.22 Max: 5.94
Current: 2.48
0.62
5.94
Price-to-Graham-Number 5.38
SNN's Price-to-Graham-Number is ranked lower than
79% of the 126 Companies
in the Global Medical Devices industry.

( Industry Median: 2.51 vs. SNN: 5.38 )
Ranked among companies with meaningful Price-to-Graham-Number only.
SNN' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.94  Med: 5.4 Max: 9.9
Current: 5.38
1.94
9.9
Earnings Yield (Greenblatt) % 7.39
SNN's Earnings Yield (Greenblatt) % is ranked higher than
85% of the 242 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. SNN: 7.39 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
SNN' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 3.3  Med: 6.7 Max: 11.4
Current: 7.39
3.3
11.4
Forward Rate of Return (Yacktman) % 10.01
SNN's Forward Rate of Return (Yacktman) % is ranked higher than
53% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 8.96 vs. SNN: 10.01 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
SNN' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 1  Med: 21.6 Max: 36.1
Current: 10.01
1
36.1

More Statistics

Revenue (TTM) (Mil) $4,669
EPS (TTM) $ 1.76
Beta0.67
Short Percentage of Float0.17%
52-Week Range $26.97 - 35.38
Shares Outstanding (Mil)457.72

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 4,796 5,030 5,240
EPS ($) 1.85 2.10 2.27
EPS without NRI ($) 1.85 2.10 2.27
EPS Growth Rate
(Future 3Y To 5Y Estimate)
22.46%
Dividends per Share ($) 0.63 0.73 0.82
» More Articles for SNN

Headlines

Articles On GuruFocus.com
Invesco European Growth Fund Adds to More Than 40 Existing Stakes Apr 04 2016 
Invesco European Growth Fund Adds to 7 Stakes Jan 26 2016 
Edwards Lifesciences a Gold Standard in the Market Dec 16 2014 
3 Dividend Kings From The U.K. I Love To Buy Aug 21 2014 
Stryker Corporation (SYK) Dividend Stock Analysis Jan 11 2013 
5 Highly Predictable Mid-/Large-Caps with ROC Over 15% Apr 21 2012 
The Best Dividends on April 18, 2012 Apr 18 2012 
5 Healthcare Stocks to Consider Today Mar 21 2012 
Stryker Corp. (SYK) Dividend Stock Analysis Dec 16 2011 

More From Other Websites
Smith & Nephew downgraded by Goldman Feb 27 2017
Smith & Nephew invests in and signs agreement to distribute disruptive Leaf Healthcare pressure... Feb 22 2017
These drug and medical device companies made the most payments to N.Y.C. hospitals Feb 14 2017
Smith & Nephew Plc :SNN-US: Earnings Analysis: 2016 By the Numbers : February 10, 2017 Feb 10 2017
FTSE 100 closes at 3-week high as BP advances Feb 09 2017
FTSE rises on insurers and banks, mid-cap index has record close Feb 09 2017
Smith & Nephew hurt by tough markets in China and Gulf states Feb 09 2017
Smith & Nephew hurt by tough markets in China and Gulf states Feb 09 2017
Smith & Nephew hurt by tough markets in China and Gulf states Feb 09 2017
Falls in Smith & Nephew, miners weigh on Britain's FTSE Feb 09 2017
FTSE 100 on course for third day of gains, with BP advancing Feb 09 2017
BUZZ-Smith & Nephew: bottom of the FTSE as China weakness hits results Feb 09 2017
Smith & Nephew hit by tough markets in China, Gulf States Feb 09 2017
Mass. lawmakers join effort to put a stake through the heart of the medical device tax Jan 24 2017
ETFs with exposure to Smith & Nephew Plc : January 11, 2017 Jan 11 2017
Press release – Cernavoda NPP reconnection to the National Power GRid Jan 06 2017
Press release – the disconnection of Cernavoda NPP Unit 1 from the national power grid Jan 06 2017
Nuclearelectrica’s position regarding the press release issued by the Ministry of Energy on... Dec 28 2016
Timing of Smith & Nephew full year results Dec 21 2016
Current report on the litigation initiated by SNN against ArcelorMittal Galati SA Dec 21 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)